Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -14.09
- Piotroski Score 2.00
- Grade Neutral
- Symbol (THAR)
- Company Tharimmune, Inc.
- Price $2.37
- Changes Percentage (9.22%)
- Change $0.2
- Day Low $1.85
- Day High $2.42
- Year High $76.50
Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic diseases. The company's pre-clinical immuno-oncology pipeline includes TH104, a product candidate for the treatment of liver-related and other pruritogenic inflammatory conditions; TH3215 and TH0059 that are product candidates used to treat various solid tumors; and TH1940, which targets programmed cell death protein 1 (PD-1). It has a research collaboration and product license agreement with Minotaur Therapeutics, Inc. for the development of proprietary targeted biologics. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was incorporated in 2017 and is headquartered in Bridgewater, New Jersey.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/26/2025
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$22.35
- Trailing P/E Ratio -0.23
- Forward P/E Ratio -0.23
- P/E Growth -0.23
- Net Income $-9,319,094
Income Statement
Quarterly
Annual
Latest News of THAR
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Katharine McPhee, 40, and David Foster, 75, Aren't 'Fighting' Age as They Celebrate Milestone Birthdays (Exclusive)
Katharine McPhee and David Foster embrace their age gap as he turns 75 and she is 40. They don't dwell on the numbers, focusing on enjoying life together. Celebrating with a concert and family, they c...
By PEOPLE.com | 2 weeks ago -
Katharine McPhee posts rare photo with son, 3, for David Foster's birthday
Katharine McPhee Foster shares a heartwarming moment with son Rennie and husband David Foster on Instagram. The family photo was taken during David's 75th birthday concert where Katharine performed wi...
By Newsweek | 2 weeks ago -
Katharine McPhee Sweetly Kisses Son Rennie, 3, as She Celebrates Husband David Foster's 75th Birthday: 'My Whole World'
Katharine McPhee Foster shared a heartwarming moment with her 3-year-old son Rennie and husband David Foster. The actress posted a photo on Instagram showing her kissing Rennie, calling him her whole ...
By PEOPLE.com | 2 weeks ago
